Professional Documents
Culture Documents
Chemotherapy 141203082111 Conversion Gate02
Chemotherapy 141203082111 Conversion Gate02
Ant ibiotics
S
(2-6h)
G2
(2-32h) Vinca alkaloids
Taxoids
Alkylating agents
G1
(2-∞h)
G0
GOALS
• CURE
Wilm’s Tumor
Hodgkuins Dse
Testicular c.
Acute Lymphoblastic
Leukemia
CONTROL
Breast
Ovarian
Colon
Lung
Lymphoma
PALLIATION
Relieve Pain
Relieve Obstruction
Improve the sense of well-
being
Chemotherapy may be used as
CYCLE-NONSPECIFIC
Alkylating Agents
› Disrupt deoxyribonucleic acid (DNA)
Carboplatin, Cisplatin,
Cyclophosphamide, Ifosfamide, Thiotepa
Antibiotics
› Bind with DNA to inhibit synthesis of
DNA and RNA
Bleomycin, doxorubicin, idarubicin,
mitomycin, mitoxantrone
Classification of Chemotherapy Drugs
CYTOPROTECTIVE AGENTS
Protect normal tissue by binding with metabolites
of other cytotoxic drugs
Dexrazoxane
Mesna
Preventing Infiltration
Use a low-pressure infusion pump to
administer vesicants through a
peripheral vein, to decrease the risk of
extravasation
Use a central venous catheter for
continuous vesicant infusions
ADMINISTERING CHEMOTHERAPEUTIC
DRUGS
Guidelines in giving vesicants
Use a distal vein that allows successive
proximal venipunctures
Avoid using the hand, antecubital space,
damaged areas, or areas with
compromised circulation
Don’t probe or “fish” for veins
Place a transparent dressing over the
site
ADMINISTERING CHEMOTHERAPEUTIC
DRUGS
Guidelines in giving vesicants (cont’n)
Start the push delivery or the
infusion with normal saline solution
Inspect the site for swelling and
erythema
Tell the patient to report burning,
stinging, pain, pruritus, or
temperature changes near the site
After drug administration, flush the
line with 20mL of NSS
ADMINISTERING CHEMOTHERAPEUTIC
DRUGS
Concluding Treatment
• Dispose of all used needles and contaminated
sharps in the orange sharps container
• Dispose of PPE’s in yellow chemotherapeutic
waste container
• Dispose of unused medications, considered
hazardous waste, according to your facility’s
policy
ADMINISTERING CHEMOTHERAPEUTIC
DRUGS
Concluding treatment (cont)
• Wash hands thoroughly
• Document the ff.
– sequence in which the drugs were administered
– site accessed, the gauge and length of the catheter, and
the number of attempts
– name, dose, and route of the administered drugs
– Type and volume of the IV solutions and adverse
reactions and nursing interventions
• According to facility policy, wear protective clothing when
handling body fluids from the patient for 48 hours after
MANAGING COMPLICATIONS OF
CHEMOTHERAPY
ALOPECIA
Hair loss that occurs as chemotherapeutic drugs
destroy the rapidly growing cells of hair follicles
May be minimal or severe
Occurs 2-3 weeks after treatment begins
Almost always temporary
Signs and Symptoms
Hair loss that may include eyebrows, lashes and
body hair
Nursing Interventions
Minimize shock and distress by warning the patient
of this possibility
Discuss with the patient why it occurs
Describe to the patient how much hair loss to expect
Emphasize to the patient the need for appropriate
head protection against sunburn
Inform the patient that new hair may be a different
texture or color
Give the patient sufficient time to decide whether to
order a wig
Inform the patient that his scalp will become sore at
times due to follicles swelling
Prevention measures
For patients with long hair, suggest cutting hair
shorter before treatment because washing and
brushing cause more hair loss
ANEMIA
Occurs as chemo drugs destroy healthy cells and
cancer cells
RBCs are destroyed and can’t be replaced by the bone
marrow
Signs and symptoms
Dizziness, fatigue, pallor, and shortness of breath
after minimal exertion
Low hemoglobin level and hematocrit
May develop slowly over several courses of treatment
Nursing Interventions
Monitor hemoglobin level, hematocrit, RBC count;
report dropping values
Be prepared to administer a blood transfusion or
erythropoietin
Prevention Measures
Instruct the patient to take frequent rests, increase
his intake of iron-rich foods, and take a
multivitamin with iron as prescribed
If the patient has been prescribed a drug such as
epoetin, make sure he understands how to take the
drug and what adverse effects he should watch for
and report
DIARRHEA
Occurs because the rapidly dividing cells of the
intestinal mucosa are killed
Complications include weight loss, F&E
imbalance, and malnutrition
Signs and symptoms
An increase in the volume of stool compared
with the patient’s normal bowel habits
Nursing Interventions
Assess frequency, color, and consistency of stool
Encourage fluids, give IV fluids and potassium
supplements as ordered
Prevention measures
Use dietary adjustments and antidiarrheal meds
Provide good perianal skin care
EXTRAVASATION
The inadvertent leakage of a vesicant solution into
the surrounding tissue
Signs and Symptoms
Initial signs and symptoms may resemble those of
infiltration – blanching, pain, swelling
Symptoms possibly progressing to blisters; to skin,
muscle, tissue and fat necrosis; and to tissue
sloughing
Blood return is an INCONCLUSIVE test and
shouldn’t be used to determine if IV catheter is
correctly seated in the peripheral vein. To assess
peripheral IV placement, flush the vein with NSS
and observe site for swelling.
Extravasation of Doxorubicin
Nursing Interventions
Stop the infusion
Check your facility’s policy to determine if the IV
catheter is to be removed or left in place to infuse
corticosteroids or a specific antidote.
Notify the physician
Instill the appropriate antidote according to facility
policy. Usually, you’ll give the antidote for
extravasation either by instilling it through the
existing IV catheter or by using a 1 mL syringe to
inject small amounts subcutaneously in a circle
around the extravasated area
After the antidote has been given, remove the IV
catheter
Preventive measures
Verify IV line patency and
placement by flushing with normal
saline sol’n
Remember, “When in doubt, take
it out!”
Use a transparent, semi-permeable
dressing for inspection of site.
INFILTRATION
The inadvertent leakage of a nonvesicant solution or
medication into the surrounding tissue
Infusion-site related
Signs and symptoms
Blanching
Change in IV flow rate
Numbness and tingling in swollen area due to nerve
compression injury leading to compartment
syndrome
Swelling around IV site (the swollen area will be cool
to touch)
Nursing Interventions
Remove the IV catheter
Insert a new IV catheter in a different
location
Prevention Measures
Check for infiltration before, during,
and after the infusion by flushing the
vein with normal saline solution
LEUKOPENIA
Reduced leukocytes or WBCs
Occurs as WBCs and cancer cells are destroyed by
chemo drugs
Signs and Symptoms
Susceptibility to Infections
Neutropenia
Nursing Interventions
Watch for the nadir, the point of lowest blood cell
count
Be prepared to administer colony-stimulating
factors
Institute neutropenic precautions
Teach the patient and caregiver about:
Good hygiene practices
Signs and symptoms of infection
The importance of checking the patient’s
temperature regularly
How to prepare low-microbe diet
How to care for vascular access devices
Instruct the patient to avoid
Crowds
People with colds or respiratory infections
Fresh fruit
Fresh flowers
plants
NAUSEA and VOMITING
Can appear in 3 different patterns
Anticipatory
Acute
Delayed
ANTICIPATORY NAUSEA and VOMITING
Signs and Symptoms
Nausea and vomiting that’s a learned response
from prior nausea and vomiting after a dose of
chemotherapy
High anxiety levels (acts as a trigger)
Nursing Interventions
Posttreatment control of nausea and vomiting
may prevent future anticipatory episodes
Prevention measures
Pretreat the patient with lorazepam (Ativan)
at least 1 hr before arriving for treatment
Patients with overwhelming anxiety may need
IV lorazepam before chemo is administered
ACUTE NAUSEA and VOMITING
Signs and symptoms
Nausea and vomiting occurring within the first 24
hours of treatment
Nursing Interventions
Treat the patient with acute nausea and vomiting
with antiemetic drugs
Dexamethasone
Granisetron
Lorazepam
Metoclopramide
Ondansetron
DELAYED NAUSEA and VOMITING
Signs and Symtoms
Nausea or vomiting starting or continuing beyond
24 hours after chemo has begun
Nursing Interventions
The administration of serotonin antagoninsts,
corticosteroids, various antihistamines,
benzodiapines, and and metoclopramide is usually
effective in treating patients
Prevention Measures
Administer antiemetic before chemo begins
Some patients with delayed nause and vomiting are
treated with an antiemetic for 3 days or longer
STOMATITIS
Inflammation of the lining of the oral
mucosa
Can spread into the esophagus and
pharynx
Signs and Symptoms
Painful mouth ulcers that range from
mild to severe appearing 3 to 7 days
after certain chemotherapeutic drugs
are given
Nursing Intervention
Instruct the patient to perform meticulous oral
hygiene
Administer topical anesthetic mixtures as
appropriate
If pain is severe, opioid analgesics may be
prescribed until the ulcers heal
Prevention Measures
Instruct the patient to suck on ice chips while
receiving certain drugs that cause stomatitis; this
decreases the blood supply to the mouth, thus
decreasing ulcer formation
THROMBOCYTOPENIA
Reduced blood platelet count
Signs and Symptoms
Bleeding gums
Coffee-ground emesis
Hematuria
Hypermenorrhea
Increased bruising
Petechiae
Tarry stools
Nursing interventions
Monitor patient’s platelet count
Avoid unnecessary IM injections or
venipuncture
If an IM injection or venipuncture is necessary,
apply pressure for at least 5 minutes; apply a
pressure to the site.
Instruct the patient to
Avoid cuts and bruises
Shave with an electric razor
Avoid blowing his nose
Stay away from irritants that would trigger sneezing
Avoid using rectal thermometers
Instruct the patient to report sudden headaches
(which could indicate potentially fatal intracranial
bleeding)
VEIN FLARE
Occurs during infusion of an irritant into the vein
Signs and Symptoms
Bright redness possibly appearing in the vein along
with blotches or hives on the affected arm
Burning pain or aching along the vein as well as up
through the arm
Nursing Interventions
If the reaction is severe, injection of an IV steroid
may be required
If the patient complains of pain or burning during
the infusion:
› Increase the dilution of the infused medication
› Decrease the infusion rate
› Restart the IV in a different vein